The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GW Pharmaceuticals PLC

Nasdaq: GWPH
Last

(U.S.) $121.40

Today's change+1.27 +1.06%
Updated March 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

GW Pharmaceuticals PLC

Nasdaq: GWPH
Last

(U.S.) $121.40

Today's change+1.27 +1.06%
Updated March 29 4:00 PM -4GMT. Delayed by at least 15 minutes.

GW Pharmaceuticals PLC up (U.S.)$1.27

GW Pharmaceuticals PLC closed up Wednesday by (U.S.)$1.27 or 1.06% to (U.S.)$121.40. Over the last five days, shares have gained 1.59% and 8.64% year to date. Shares have outperformed the S&P 500 by 47.04% during the last year.

Key company metrics

  • Open(U.S.) $120.05
  • Previous close(U.S.) $120.13
  • High(U.S.) $123.34
  • Low(U.S.) $120.05
  • Bid / Ask(U.S.) $99.00 / (U.S.) $121.80
  • YTD % change+8.64%
  • Volume216,325
  • Average volume (10-day)232,281
  • Average volume (1-month)325,662
  • Average volume (3-month)407,974
  • 52-week range(U.S.) $69.12 to (U.S.) $137.88
  • Beta2.71
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEG0.45×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$3.28
Updated March 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.38%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2223
Total other revenue--------
Total revenue2223
Gross profit1122
Total cost of revenue1111
Total operating expense20262125
Selling / general / administrative7763
Research & development25242626
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-18-25-18-22
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-24-18-22
Income after tax-16-17-12-17
Income tax, total-3-8-6-5
Net income-16-17-12-17
Total adjustments to net income--------
Net income before extra. items-16-17-12-17
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-16-17-12-17
Inc. avail. to common incl. extra. items-16-17-12-17
Diluted net income-16-17-12-17
Dilution adjustment--------
Diluted weighted average shares303295263263
Diluted EPS excluding extraordinary itemsvalue per share-0.05-0.06-0.05-0.06
Dividends per sharevalue per share----0.000.00
Diluted normalized EPSvalue per share-0.05-0.06-0.05-0.06